Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) June 10, 2025
LI Jijie, HOU Lisha, ZHU Ping. et al. Sample Size Calculation using SAS for PhaseⅡin Two-stage Clinical Trials of Anti-tumor Drugs[J]. Journal of Sichuan University (Medical Sciences), 2017, 48(4): 600-604.
Citation: LI Jijie, HOU Lisha, ZHU Ping. et al. Sample Size Calculation using SAS for PhaseⅡin Two-stage Clinical Trials of Anti-tumor Drugs[J]. Journal of Sichuan University (Medical Sciences), 2017, 48(4): 600-604.

Sample Size Calculation using SAS for PhaseⅡin Two-stage Clinical Trials of Anti-tumor Drugs

More Information
  • Published Date: July 19, 2023
  • Objective To compare Gehan two-stage design and Simon two-stage design in sample size calculations for phase Ⅱ clinical trials of anti-tumor drugs. Methods We explained the sample size calculation methods with a single-stage design, Gehan two-stage design, and Simon optimal two-stage and minimax two-stage designs in line with the principle of exact binomial probability. By setting up different parameters in SAS macro program, the advantages and disadvantages of these designs were compared. Results The minimax two-stage design does not increase the maximum sample size compared with the single-stage design. Compared with the Gehan two-stage design, the Simon two-stage design has the advantage of being able to determine an early termination of trials when no or low anti-tumor activities are evident. Conclusion Simon two-stage design is better than single-stage design and Gehan two-stage design. The minimax design is more popular than the optimal design.
  • Related Articles

    [1]WANG Shan-shan, GUO Zhan-ping, ZHAO Xiang-yu. Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for Helicobacter pylori-Positive Early-Stage Gastric Cancer[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2023, 54(1): 186-191. DOI: 10.12182/20230160111
    [2]WANG Han, WANG Yue-long, LIU Zhi-yong, XU Jian-guo. Targeted Drug Therapy for Intracranial Tumors[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2022, 53(4): 564-572. DOI: 10.12182/20220760102
    [3]LI Tao, WEI Qiang, WU Lin, CHEN Meng, ZHANG Li-ping, ZHANG Qian, LIU Xing-hui. Multicenter, Randomized, Double-Blind, and Positive Drug-Controlled Clinical Trial on Prevention of Postpartum Hemorrhage after Vaginal Delivery with Ergometrine Maleate[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2022, 53(2): 316-320. DOI: 10.12182/20220360503
    [4]CHEN Hong, HU Xiang, ZHANG Hui-yuan, HU Hong-bo. Induction and Anti-Tumor Function of Tertiary Lymphoid Organs[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2022, 53(1): 35-42. DOI: 10.12182/20220160102
    [5]LUO Li-mei, XIE Yi, NIU Qian, MA Ying, CHEN Jie, BAI Yang-juan, WANG Lan-lan. Course Design and Discussions of Integrating Ideological and Political Theories Education in Medical Laboratory Pathways and Their Clinical Application[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2021, 52(5): 747-753. DOI: 10.12182/20210960302
    [6]LI Man, LI Jian-ping, WANG Ya-shi, HE Qin. Construction and Anti-tumor Effect Evaluation of a Dual-Responsive Hyaluronic Acid Carbon Quantum Dot-Gelatin Nano-Drug Delivery System[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2021, 52(4): 577-584. DOI: 10.12182/20210760103
    [7]LUO Zhu, LIU Chun-tao, WU Chang-gui. et al. Efficacy and Safety of Tiotropium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease——a Multi-center Randomized Clinical Trial[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2015, 46(3): 485-487.
    [8]XU Hao, ZHANG Tao, LI Xiao-song. et al. Calculating Pearson Residual in Logistic Regressions: a Comparison Between SPSS and SAS[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2015, 46(1): 129-132.
    [9]LI Cai-zheng, SUN Jia-yu, WANG Ying. et al. Phase I Clinical Trial on the Safety of Injectable Cefetamet Sodium with a Single Dose in Healthy Volunteers[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2014, 45(4): 637-641.
    [10]LUO Zhu, LIU Chun-tao, HUANG Yi-jiang. et al. A Muti-center, Randomized, Double-blind, Positive Controlled Clinical Trial of Salbutamol Sulfate MDI without[J]. JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES), 2014, 45(2): 266-269.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return